C-SATS vs VirtaMed
A simulation center training first-year residents has no use for C-SATS. It grades video captured from minimally invasive cases, and novices without operating-room access have none to upload. That buyer takes VirtaMed, whose simulators pair haptics with original instruments for arthroscopy, laparoscopy, gynecology, urology and robotic surgery. VirtaMed AG of Schlieren sells them as a capital purchase, and CAE Healthcare distributes. Trial evidence sits at the training level: in a 2024 crossover of LaparoS, LapSim and LapMentor III, all trainees improved, and the vendor says ArthroS has been in the Swiss orthopedic board exam since 2013.
A general surgery department that already operates and wants its surgeons' technique benchmarked goes the other way, to C-SATS, a J&J MedTech product. Neither vendor states an FDA status, and neither publishes a price.
Surgical AI · Reviewed November 1, 2026
When to pick each one
C-SATS
- Reviews cases surgeons already operate and record
- Crowd-sourced review is part of the method
- Enterprise pricing, no public figure
VirtaMed
- Haptic simulators with original instruments
- Vendor says ArthroS is in the Swiss orthopedics board exam
- Distributed by CAE Healthcare
Score
Each row shows points earned of points available under the published rubric.
C-SATS
36of 100
VirtaMed
37of 100
| Dimension | C-SATS | VirtaMed | Difference |
|---|---|---|---|
| FDA clearance | 0 / 18 | 0 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 1.4 | 0 / 1.4 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 0.8 | 0 / 0.8 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 14.7 / 21 | 0 |
| RCT / meta-analysis / systematic review | 3.9 / 7.8 | 7.8 / 7.8 | -3.9 |
| Funding & adoption signal | 6 / 12 | 3 / 12 | +3 |
| Pricing transparency | 5 / 5 | 5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
C-SATS
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | n/a | n/a | Enterprise. |
VirtaMed
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | n/a | n/a | Enterprise capital purchase. |
Evidence
C-SATS
FDA decisions
No FDA decision cited in our research as of October 20, 2026.
Peer-reviewed
3 PubMed records name C-SATS.
- Evaluating the evaluators: does C-SATS measure up? (opens in new tab)
- Barriers to the adoption of routine surgical video recording: a mixed-methods qualitative study of a real-world implementation of a video recording platform. (opens in new tab)
- Cloud Based AI-Driven Video Analytics (CAVs) in Laparoscopic Surgery: A Step Closer to a Virtual Portfolio. (opens in new tab)
VirtaMed
FDA decisions
No FDA decision cited in our research as of October 20, 2026.
Peer-reviewed
3 PubMed records name VirtaMed.
- Hip Arthroscopy Simulator Training With Immersive Virtual Reality Has Similar Effectiveness to Nonimmersive Virtual Reality. (opens in new tab)
- Virtual reality simulation training in laparoscopic surgery - does it really matter, what simulator to use? Results of a cross-sectional study. (opens in new tab)
- Arthroscopic approach in initial training: Study of a novice cohort using inverse direct and indirect approaches and its implication in the development of training programs. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | C-SATS | VirtaMed |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | CH |
Scroll horizontally to see both columns.
Common questions
Open the full surgical ai comparison
Surgical video intelligence (Theator), OR analytics (OR Black Box), VR training (Osso VR, FundamentalVR), robotic AI (da Vinci 5 Case Insights). Mostly enterprise capital purchases.